topics fresenius 
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 7, 2022
Spectrum Solutions LLC, JSR Corporation, and Fresenius Kabi USA LLC. Denials of institution – particularly the extent to which they are reviewable – have long been a contentious topic for the PTAB. Of the cases that reached an institution decision, 75% were instituted – the same percentage that were instituted in 2020.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Stimufend ® (Fresenius Kabi). The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., SB8 (Samsung Bioepis).
Expert insights. Personalized for you.
52 
Let's personalize your content